200 related articles for article (PubMed ID: 19624478)
1. Accuracy of WHO CD4 cell count criteria for virological failure of antiretroviral therapy.
Keiser O; MacPhail P; Boulle A; Wood R; Schechter M; Dabis F; Sprinz E; Egger M;
Trop Med Int Health; 2009 Oct; 14(10):1220-5. PubMed ID: 19624478
[TBL] [Abstract][Full Text] [Related]
2. Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes.
Ledergerber B; Lundgren JD; Walker AS; Sabin C; Justice A; Reiss P; Mussini C; Wit F; d'Arminio Monforte A; Weber R; Fusco G; Staszewski S; Law M; Hogg R; Lampe F; Gill MJ; Castelli F; Phillips AN;
Lancet; 2004 Jul 3-9; 364(9428):51-62. PubMed ID: 15234856
[TBL] [Abstract][Full Text] [Related]
3. CD4 criteria improves the sensitivity of a clinical algorithm developed to identify viral failure in HIV-positive patients on antiretroviral therapy.
Evans DH; Fox MP; Maskew M; McNamara L; MacPhail P; Mathews C; Sanne I
J Int AIDS Soc; 2014; 17(1):19139. PubMed ID: 25227265
[TBL] [Abstract][Full Text] [Related]
4. Utility of CD4 cell counts for early prediction of virological failure during antiretroviral therapy in a resource-limited setting.
Badri M; Lawn SD; Wood R
BMC Infect Dis; 2008 Jul; 8():89. PubMed ID: 18601727
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of antiretroviral therapy failure in Malawi: poor performance of clinical and immunological WHO criteria.
van Oosterhout JJ; Brown L; Weigel R; Kumwenda JJ; Mzinganjira D; Saukila N; Mhango B; Hartung T; Phiri S; Hosseinipour MC
Trop Med Int Health; 2009 Aug; 14(8):856-61. PubMed ID: 19552661
[TBL] [Abstract][Full Text] [Related]
6. Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment.
Srasuebkul P; Ungsedhapand C; Ruxrungtham K; Boyd MA; Phanuphak P; Cooper DA; Law MG
HIV Med; 2007 Jan; 8(1):46-54. PubMed ID: 17305932
[TBL] [Abstract][Full Text] [Related]
7. The role of targeted viral load testing in diagnosing virological failure in children on antiretroviral therapy with immunological failure.
Davies MA; Boulle A; Technau K; Eley B; Moultrie H; Rabie H; Garone D; Giddy J; Wood R; Egger M; Keiser O;
Trop Med Int Health; 2012 Nov; 17(11):1386-90. PubMed ID: 22974345
[TBL] [Abstract][Full Text] [Related]
8. Nevirapine/zidovudine/lamivudine has superior immunological and virological responses not reflected in clinical outcomes in a 48-week randomized comparison with abacavir/zidovudine/lamivudine in HIV-infected Ugandan adults with low CD4 cell counts.
Munderi P; Walker AS; Kityo C; Babiker AG; Ssali F; Reid A; Darbyshire JH; Grosskurth H; Mugyenyi P; Gibb DM; Gilks CF;
HIV Med; 2010 May; 11(5):334-44. PubMed ID: 20136661
[TBL] [Abstract][Full Text] [Related]
9. Accuracy of immunological criteria for identifying virological failure in children on antiretroviral therapy - the IeDEA Southern Africa Collaboration.
Davies MA; Boulle A; Eley B; Moultrie H; Technau K; Rabie H; van Cutsem G; Giddy J; Wood R; Egger M; Keiser O;
Trop Med Int Health; 2011 Nov; 16(11):1367-71. PubMed ID: 21834797
[TBL] [Abstract][Full Text] [Related]
10. Clinically relevant thresholds for ultrasensitive HIV drug resistance testing: a multi-country nested case-control study.
Inzaule SC; Hamers RL; Noguera-Julian M; Casadellà M; Parera M; Kityo C; Steegen K; Naniche D; Clotet B; Rinke de Wit TF; Paredes R;
Lancet HIV; 2018 Nov; 5(11):e638-e646. PubMed ID: 30282603
[TBL] [Abstract][Full Text] [Related]
11. Detecting virological failure in HIV-infected Tanzanian children.
Mgelea EM; Kisenge R; Aboud S
S Afr Med J; 2014 Jun; 104(10):696-9. PubMed ID: 25363057
[TBL] [Abstract][Full Text] [Related]
12. Comparison of dynamic monitoring strategies based on CD4 cell counts in virally suppressed, HIV-positive individuals on combination antiretroviral therapy in high-income countries: a prospective, observational study.
Caniglia EC; Cain LE; Sabin CA; Robins JM; Logan R; Abgrall S; Mugavero MJ; Hernández-Díaz S; Meyer L; Seng R; Drozd DR; Seage GR; Bonnet F; Dabis F; Moore RD; Reiss P; van Sighem A; Mathews WC; Del Amo J; Moreno S; Deeks SG; Muga R; Boswell SL; Ferrer E; Eron JJ; Napravnik S; Jose S; Phillips A; Justice AC; Tate JP; Gill J; Pacheco A; Veloso VG; Bucher HC; Egger M; Furrer H; Porter K; Touloumi G; Crane H; Miro JM; Sterne JA; Costagliola D; Saag M; Hernán MA; ;
Lancet HIV; 2017 Jun; 4(6):e251-e259. PubMed ID: 28411091
[TBL] [Abstract][Full Text] [Related]
13. Immunological and virological responses to highly active antiretroviral therapy in a non-clinical trial setting in a developing Caribbean country.
Kilaru KR; Kumar A; Sippy N; Carter AO; Roach TC
HIV Med; 2006 Mar; 7(2):99-104. PubMed ID: 16420254
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the WHO criteria for antiretroviral treatment failure among adults in South Africa.
Mee P; Fielding KL; Charalambous S; Churchyard GJ; Grant AD
AIDS; 2008 Oct; 22(15):1971-7. PubMed ID: 18784460
[TBL] [Abstract][Full Text] [Related]
15. Performance of immunological response in predicting virological failure.
Ingole N; Mehta P; Pazare A; Paranjpe S; Sarkate P
AIDS Res Hum Retroviruses; 2013 Mar; 29(3):541-6. PubMed ID: 23137294
[TBL] [Abstract][Full Text] [Related]
16. Viral load predicts new world health organization stage 3 and 4 events in HIV-infected children receiving highly active antiretroviral therapy, independent of CD4 T lymphocyte value.
Oliveira R; Krauss M; Essama-Bibi S; Hofer C; Robert Harris D; Tiraboschi A; de Souza R; Marques H; Succi R; Abreu T; Della Negra M; Hazra R; Mofenson LM; Siberry GK;
Clin Infect Dis; 2010 Dec; 51(11):1325-33. PubMed ID: 21039218
[TBL] [Abstract][Full Text] [Related]
17. Long-term trends in CD4 cell counts and impact of viral failure in individuals starting antiretroviral therapy: UK Collaborative HIV Cohort (CHIC) study.
Hughes RA; Sterne JA; Walsh J; Bansi L; Gilson R; Orkin C; Hill T; Ainsworth J; Anderson J; Gompels M; Dunn D; Johnson MA; Phillips AN; Pillay D; Leen C; Easterbrook P; Gazzard B; Fisher M; Sabin CA
HIV Med; 2011 Nov; 12(10):583-93. PubMed ID: 21569188
[TBL] [Abstract][Full Text] [Related]
18. Accuracy of WHO immunological criteria in identifying virological failure among HIV-infected adults on First line antiretroviral therapy in Mwanza, North-western Tanzania.
Gunda DW; Kidenya BR; Mshana SE; Kilonzo SB; Mpondo BC
BMC Res Notes; 2017 Jan; 10(1):45. PubMed ID: 28095920
[TBL] [Abstract][Full Text] [Related]
19. Second-line treatment in the Malawi antiretroviral programme: high early mortality, but good outcomes in survivors, despite extensive drug resistance at baseline.
Hosseinipour MC; Kumwenda JJ; Weigel R; Brown LB; Mzinganjira D; Mhango B; Eron JJ; Phiri S; van Oosterhout JJ
HIV Med; 2010 Sep; 11(8):510-8. PubMed ID: 20345885
[TBL] [Abstract][Full Text] [Related]
20. The role of baseline HIV-1 RNA, drug resistance, and regimen type as determinants of response to first-line antiretroviral therapy.
Di Biagio A; Rusconi S; Marzocchetti A; Signori A; Schiavetti I; Bruzzone B; Monno L; Punzi G; Colao MG; Penco G; Zazzi M; De Luca A;
J Med Virol; 2014 Oct; 86(10):1648-55. PubMed ID: 25042976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
